122 related articles for article (PubMed ID: 4145866)
1. The relationship between blood levels of different forms of butaperazine and clinical response.
Simpson GM; Lament R; Cooper TB; Lee JH; Bruce RB
J Clin Pharmacol; 1973 Jul; 13(7):288-97. PubMed ID: 4145866
[No Abstract] [Full Text] [Related]
2. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics.
Keskiner A; Itil TM; Todt N
Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278
[No Abstract] [Full Text] [Related]
3. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
Gershon S; Hekimian LJ; Burdock EI; Park S; Floyd A
Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420
[No Abstract] [Full Text] [Related]
4. Butaperazine (Repoise).
Med Lett Drugs Ther; 1968 Nov; 10(22):89-90. PubMed ID: 4389275
[No Abstract] [Full Text] [Related]
5. Piperacetazine in ambulatory chronic schizophrenic patients.
Rada RT; Donlon PT
Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
[No Abstract] [Full Text] [Related]
6. Relationship of butaperazine blood levels to plasma prolactin in chronic schizophrenic patients.
Smith RC; Tamminga CA; Crayton JW; Dekirmenjian H; Davis JM
Psychopharmacology (Berl); 1979; 66(1):29-33. PubMed ID: 44374
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
Kiev A; Güclü B; Kulkarni AS
Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
[No Abstract] [Full Text] [Related]
8. Evaluation of Mesoridazine. (Serentil).
JAMA; 1971 Apr; 216(2):313-4. PubMed ID: 5107916
[No Abstract] [Full Text] [Related]
9. The pharmacokinetics of butaperazine in serum.
Davis JM; Janowsky DS; Sekerke HJ; Manier H; el-Yousef MK
Adv Biochem Psychopharmacol; 1974; 9(0):433-43. PubMed ID: 4151767
[No Abstract] [Full Text] [Related]
10. Sensitivity to a phenothiazine (butaperazine).
Simpson GM; Laska E
Can Psychiatr Assoc J; 1968 Dec; 13(6):499-506. PubMed ID: 4387257
[No Abstract] [Full Text] [Related]
11. Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cell bound butaperazine.
Garver DL; Dekirmenjian H; Davis JM; Casper R; Ericksen S
Am J Psychiatry; 1977 Mar; 134(3):304-7. PubMed ID: 14514
[TBL] [Abstract][Full Text] [Related]
12. A controlled study of mesoridazine: an effective treatment for schizophrenia.
McIndoo MV
South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
[No Abstract] [Full Text] [Related]
13. The differential response to parenteral chlorpromazine and mesoridazine in psychotic patients.
Brauzer B; Goldstein BJ
J Clin Pharmacol J New Drugs; 1970; 10(2):126-31. PubMed ID: 4906541
[No Abstract] [Full Text] [Related]
14. Butaperazine pharmacokinetics. Effect of dosage regimen on steady state blood levels.
Cooper TB; Simpson GM; Haher EF; Bergner PE
Arch Gen Psychiatry; 1975 Jul; 32(7):903-5. PubMed ID: 239664
[TBL] [Abstract][Full Text] [Related]
15. Relation of plasma prolactin to clinical response in schizophrenic patients.
Gruen PG; Sachar EJ; Altman N; Langer G; Tabrizi MA; Halpern FS
Arch Gen Psychiatry; 1978 Oct; 35(10):1222-7. PubMed ID: 29592
[TBL] [Abstract][Full Text] [Related]
16. Phenothiazine levels in plasma and red blood cells. Their relationship to clinical improvement in schizophrenia.
Casper R; Garver DL; Dekirmenjian H; Chang S; Davis JM
Arch Gen Psychiatry; 1980 Mar; 37(3):301-5. PubMed ID: 6102458
[TBL] [Abstract][Full Text] [Related]
17. Effects of conjugated estrogens on plasma butaperazine levels.
El-Yousef MK; Manier DH
Psychopharmacologia; 1974; 39(1):39-41. PubMed ID: 4153665
[No Abstract] [Full Text] [Related]
18. Evaluation of a new antipsychotic agent. Butaperazine maleate (repoise maleate).
JAMA; 1968 Dec; 206(10):2307-8. PubMed ID: 4386884
[No Abstract] [Full Text] [Related]
19. Plasma butaperazine levels in long-term chronic non-responding schizophrenics.
Smith RC; Dekirmenjian H; Davis JM; Crayton J; Evans H
Commun Psychopharmacol; 1977; 1(4):319-24. PubMed ID: 28201
[No Abstract] [Full Text] [Related]
20. Butaperazine in chronic schizophrenic patients: a doubled-blinf study.
Brotman RK; Muzekari LH; Shanken PM
Curr Ther Res Clin Exp; 1969 Jan; 11(1):5-8. PubMed ID: 4387485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
